Heart Association Advised Against Cuffless Blood Pressure Use
The group warns that emerging wearable technology should not yet replace traditional clinical methods for diagnosis.
Updated on Sept. 24, 2026 in Heart Disease
Live Poll
Do you trust wearable devices to accurately track your blood pressure at home?
The American Heart Association issued a 2025 scientific statement cautioning against using cuffless blood pressure devices for clinical diagnosis or treatment. This guidance affects the roughly 122 million adults in the United States currently managing high blood pressure.
Why it matters
High blood pressure remains a critical risk factor for stroke, heart attack, and heart failure, making accurate monitoring essential for management. This guidance helps clarify how patients and providers should integrate new wearable technology into clinical decision-making.
A 2026 study linked wrist-type nocturnal monitors to improved sleep-quality scores, while another 2026 study validated a ring-type device for detecting blood pressure variations. It remains unclear how these findings reconcile with current clinical diagnostic standards.
The players
American Heart Association
A national nonprofit organization focused on cardiovascular health and research that establishes clinical guidelines.
Food and Drug Administration
The federal agency responsible for regulating medical devices to ensure safety and effectiveness for public use.
Sky Labs
A medical device company that develops wearable sensors for heart health and cardiovascular monitoring.
The details
Wearable devices measure blood pressure using wrist, finger, or skin-based sensors to provide continuous data. Some models, like the Huawei Watch D2, attempt to mimic standard measurements by utilizing a miniaturized airbag cuff within the wristband to compress the artery.
Timeline
September 2025: Sky Labs launched the CART BP ring.
January 2026: The FDA issued draft guidance for cuffless blood pressure devices.
April 2026: Sky Labs launched the CART ON device.
September 2026: Pixel Watch and Fitbit added blood pressure trend tracking.
Health Landscape
The market is segmenting into regulated measurement devices, hypertension detection tools, and wellness-trend products. This transition follows the FDA's 2026 draft guidance for cuffless non-invasive blood pressure devices.
If you are currently tracking your blood pressure with a wearable, continue to prioritize readings from a traditional, validated cuff monitor for clinical decisions. It is worth discussing with your doctor how to safely incorporate wearable trend data into your existing treatment plan.
The takeaway
While wearable devices offer a convenient way to track daily trends, they are not currently a substitute for clinical-grade diagnostic tools. Always verify any concerning fluctuations with your physician using a traditional, validated monitoring device.
Further reading
For more on managing cardiovascular metrics, visit Heart Disease.
Source note: This article includes information reported by Miami Herald.
Live Poll
Do you trust wearable devices to accurately track your blood pressure at home?
